TickerKhojComparison · NSE · data 2026-11-02
Amanta Healthcare Limited vs Kilitch Drugs (India) Limited
In plain words
Size: Kilitch Drugs (India) Limited is about 1.1 times the market value of Amanta Healthcare Limited.
Valuation (P/E): Amanta Healthcare Limited 44 vs Kilitch Drugs (India) Limited 23.7.
Return on equity: Kilitch Drugs (India) Limited 12.5% vs Amanta Healthcare Limited 9.4%.
Debt to equity: Amanta Healthcare Limited 1.11 vs Kilitch Drugs (India) Limited 0.32.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AMANTA | KILITCH | |
|---|---|---|
| Price | ₹166.35 | ₹206.81 |
| Market cap | ₹632 cr | ₹703 cr |
| P/E | 44 | 23.7 |
| P/B | — | — |
| ROE | 9.4% | 12.5% |
| ROCE | 11.5% | 12.3% |
| Debt / equity | 1.11 | 0.32 |
| Operating margin | 14.0% | 13.7% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 3.5% | 19.0% |
| Profit growth, 3 years (yearly) | — | 42.4% |
| 1-year return | 36.9% | 6.8% |
| Revenue, last 12 months | ₹291 cr | ₹237 cr |
| Net profit, last 12 months | ₹15 cr | ₹30 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹3 cr | ₹3 cr |
| Quarter profit vs a year earlier | -5.7% | -4.0% |
| Promoter holding | 63.80% | 63.77% |
| Health check | Average (5.3/10) | Strong (7.2/10) |
Common questions
Which has a higher P/E, Amanta Healthcare Limited or Kilitch Drugs (India) Limited?
Amanta Healthcare Limited trades at the higher P/E (44 against 23.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Kilitch Drugs (India) Limited (12.5% against 9.4%).
Which carries more debt?
Amanta Healthcare Limited has the higher debt-to-equity ratio (1.11 against 0.32).